Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00426491 · ClinicalTrials.gov registry record · Phase 3
Misoprostol for Non-Viable Pregnancies
A Phase 3 study, sponsored by Madigan Army Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00426491 is a Phase 3 study that has completed, run by Madigan Army Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT00426491, a Phase 3 study, has completed, sponsored by Madigan Army Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effectiveness of Misoprostol (Cytotec; GD Searle and Co., Chicago, IL) for the management of non-viable first trimester pregnancies. Specifically, Misoprostol (15-S-15-methyl PGE1) will be compared to a placebo with expectant management in who have documented non-viable gestations. We will examine the following outcome variables: time to resolution, number of patients requiring dilation and curettage, change in hematocrit, cost to the institution, patient satisfaction, and reported side effects.
Interventions
- DRUG Misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 1999-03 |
| Est. Completion | 2006-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00426491
The ClinicalTrials.gov registry entry for NCT00426491 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Madigan Army Medical Center, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Misoprostol is the first listed.
NCT00426491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00426491 about?
NCT00426491 is a clinical study titled "Misoprostol for Non-Viable Pregnancies". The purpose of this study is to examine the effectiveness of Misoprostol (Cytotec; GD Searle and Co., Chicago, IL) for the management of non-viable first trimester pregnancies. Specifically, Misoprostol (15-S-15-methyl PGE1) will be compared to a placebo with expectant management in who have documen...
What is the current status of trial NCT00426491?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 1999-03. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00426491?
The interventions under investigation include: Misoprostol (DRUG).
Who is sponsoring clinical trial NCT00426491?
This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.